Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

GUT-commensal Strain for Cancer Assessment and Notification

Project description

Bacterial detection of colorectal cancer

Colorectal cancer is the second leading cause of cancer-related deaths worldwide, according to the World Health Organization. Unfortunately, screening methods often miss early-stage colorectal cancer or mistake it for benign conditions. Supported by the Marie Skłodowska-Curie Actions programme, the GUT-SCAN project aims to solve this. It is engineering a living bacterial system that can survive in the gut and detect colorectal cancer biomarkers directly inside the body. The project’s goal is to turn a safe gut bacterium into a biosensor that identifies disease signals in real time. GUT-SCAN will work to ultimately enable earlier and more accurate cancer detection via low-cost, large-scale screening.

Objective

Colorectal cancer is one of the deadliest cancers in the European Union, claiming over 158,956 lives in 2022 alone. Despite its slow progression—typically over 10-15 years—early detection remains a major challenge. Current screening programs primarily rely on Fecal Immunochemical Tests, which detect hidden blood in stool. However, these tests often fail to identify non-bleeding cancers and can yield false positives due to benign lesions like polyps. Here, I hypothesize that engineering a living bacterial platform can enable on-site detection of colorectal cancer-specific biomarkers within the gastrointestinal tract. To achieve this, the system should ideally: i) utilize adequate bacterial models capable of persisting in the gastrointestinal tract, and ii) develop a robust platform for detecting biomarkers. In this project, I will use my expertise in bacterial engineering focused on clinical applications to transform a safe, abundant and genetically tractable gut-commensal into a microbial-based diagnostic tool. This platform will offer a low-cost, scalable solution for mass screening campaigns—not only for colorectal cancer. This innovation, therefore, has broad translational potential and will pave the way to a new frontier in microbial-based diagnostic tools and bacterial-based therapies.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

VIB VZW
Net EU contribution
€ 200 400,00
Address
SUZANNE TASSIERSTRAAT 1
9052 ZWIJNAARDE - GENT
Belgium
Region
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Activity type
Research Organisations
Links
Total cost
No data